back to US directory
us clinical guidance

Palpable breast mass: initial imaging and referral

Age- and context-matched ACR imaging, clinical鈥搑adiologic concordance and tissue diagnosis for a new palpable breast finding.

JurisdictionUnited States
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceUnited States healthcare professionals
This is an iatroX educational summary of named United States sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Use the named authority, current FDA labeling, applicable state law, payer rules and local protocol where relevant.

Scope of this summary

Adolescents and adults with a new palpable breast or chest-wall finding. This is a diagnostic pathway, not routine screening. Pregnancy, lactation, implants, prior breast cancer, inflammatory change and male breast symptoms alter imaging and referral choices.
sources for this section:ACR Breast Masses

The Bottom Line

  • Document the exact palpable target and perform a careful bilateral breast and regional-node examination; a new dominant mass requires diagnostic evaluation even when a recent screening mammogram was normal.
  • For patients aged 40 years or older, diagnostic digital breast tomosynthesis or diagnostic mammography is usually appropriate initial imaging, with targeted ultrasound added according to the finding.
  • For patients younger than 30, targeted ultrasound is generally the initial test; from age 30 to 39, ultrasound and diagnostic mammography or tomosynthesis are selected from risk and clinical context.
  • Biopsy a suspicious imaging or clinical finding using an image-guided technique that supports definitive pathology, and place a marker when appropriate under the local breast-imaging protocol.
  • Demand clinical鈥搃maging鈥損athology concordance: benign imaging or pathology does not close the case when the palpable abnormality is persistent, enlarging or clinically discordant.
sources for this section:ACR Breast Masses

Practical clinical workflow

1
Record duration, cycle relation, pain, nipple discharge or inversion, skin change, pregnancy or lactation, trauma, prior imaging or biopsy, hormone exposure and personal or inherited breast-cancer risk.
2
Examine and map size, mobility, depth and clock-face location; inspect skin and nipple and palpate axillary and supraclavicular nodes so the imaging order identifies the exact target.
3
Order diagnostic鈥攏ot screening鈥攊maging using the ACR age and circumstance variant, sending prior studies for comparison and communicating pregnancy or lactation.
4
For BI-RADS management, arrange the recommended interval imaging, image-guided core biopsy or breast specialist referral and verify that pathology explains the target.
5
Communicate results and ownership directly, including what to do if the mass persists despite a benign report or if a short-interval study is missed.
sources for this section:ACR Breast Masses

Safety boundaries and escalation

  • Rapid diffuse erythema, edema or peau d鈥檕range, a hard fixed mass, suspicious nodes or progressive nipple retraction requires prompt breast-specialist assessment and must not be treated repeatedly as infection alone.
  • A breast abscess with sepsis needs urgent drainage and antimicrobial care; a nonresolving inflammatory presentation still requires malignancy evaluation.
  • Bloody spontaneous unilateral discharge follows a dedicated diagnostic pathway even without a discrete mass.
  • Do not reassure solely from young age, a normal screening study or a benign-appearing first test when the physical finding is discordant.
sources for this section:ACR Breast Masses

Localization

US care uses ACR diagnostic imaging variants and BI-RADS-linked management rather than a universal two-week-wait referral. State and payer access affect routing, but not the need to complete concordant diagnostic assessment.
sources for this section:ACR Breast Masses

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. American College of RadiologyACR Appropriateness Criteria: Palpable Breast Massesrevised 2022 路 published 2022-10-01 路 accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the US question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.